share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰制药 | 4:持股变动声明-高管 Bozic Carmen
美股SEC公告 ·  07/12 16:12
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 10, 2024. The transaction was executed at a price of $487.34 per share, resulting in a total sale value of approximately $1,111,135. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals total 27,819 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Vertex Pharmaceuticals Inc. EVP and CMO, Carmen Bozic, completed a sale of 2,280 shares of company stock on July 10, 2024. The transaction was executed at a price of $487.34 per share, resulting in a total sale value of approximately $1,111,135. Following the sale, Bozic's direct holdings in Vertex Pharmaceuticals total 27,819 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
福泰制药公司执行副总裁兼首席医疗官卡门·博齐克(Carmen Bozic)于2024年7月10日出售了2280股公司股票。交易价格为每股487.34美元,总销售价值约为1111135美元。在出售后,博齐克在福泰制药的直接持股总数为27819股。该销售是通过公开市场交易完成的,如公司的最新报告所述。
福泰制药公司执行副总裁兼首席医疗官卡门·博齐克(Carmen Bozic)于2024年7月10日出售了2280股公司股票。交易价格为每股487.34美元,总销售价值约为1111135美元。在出售后,博齐克在福泰制药的直接持股总数为27819股。该销售是通过公开市场交易完成的,如公司的最新报告所述。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息